Labcorp Finalizes Strategic Relationship with Jefferson Health

Labcorp has completed the transaction that establishes a strategic relationship with Jefferson Health, the largest health system serving the greater Philadelphia and Southern New Jersey region.

“This groundbreaking agreement between Jefferson and Labcorp will better serve providers and patients throughout the greater Philadelphia and southern New Jersey region by increasing access, breadth of testing and affordability, as well as enriching the academic prowess and reach of Jefferson Health,” said Bill Haas, senior vice president of Labcorp’s Northeast Division. “This transaction further demonstrates our commitment to advancing our laboratory services model with leading academic health systems, and we are looking forward to building upon Jefferson’s longstanding track record of delivering comprehensive diagnostic care to its patients.”

Through the collaboration, the scope and productivity of Jefferson’s current offerings will expand, and healthcare access is expected to improve for underserved communities in Philadelphia and the surrounding areas. The new relationship is also expected to help standardize laboratory testing across the entire health system, creating consistency and optimizing patient care and safety at all locations.

Leveraging Jefferson’s pathology and laboratory expertise, the Jefferson laboratory will continue to provide services for all inpatients and outpatients along with select specialty testing, including anatomic pathology, genomics and molecular virology. Additionally, Labcorp and Jefferson will work together to establish the Innovation Driving Excellence in Academics (IDEA) initiative, which will foster innovation and advance testing capabilities and technologies to improve health outcomes.

“By combining Jefferson’s history of outstanding, leading-edge service with Labcorp’s comprehensive capabilities and resources, we are confident these offerings will make it easier for both physicians and patients to seamlessly receive high-quality, timely laboratory services in the most cost effective and efficient manner,” said Mark Whalen, executive vice president and chief strategy and administrative officer of Jefferson. “In addition, this relationship will enable us to further our academic mission by expanding residency and fellowship training opportunities in the areas of pathology and laboratory medicine.”

To access more business news, visit NJB News Now.

Related Articles: